Is Invesco RAFI Developed Markets ex-U.S. ETF (PXF) a Strong ETF Right Now?

The Invesco RAFI Developed Markets ex-U.S. ETF (PXF), a $2.16 billion smart beta fund tracking the FTSE RAFI Developed ex-U.S. Index through fundamental weighting, has delivered strong recent performance, with returns of 30.26% overall and 24.57% year-to-date/one-year as of August 25, 2025. While offering broad diversification across 1147 holdings and a medium risk profile, its 0.43% expense ratio is notably higher than comparable alternatives like Vanguard International High Dividend Yield ETF (VYMI) at 0.17% and Schwab Fundamental International Equity ETF (FNDF) at 0.25%, which could impact its long-term competitive positioning despite its current gains.

Analysis

The Invesco RAFI Developed Markets ex-U.S. ETF (PXF) is a $2.16 billion smart beta fund providing fundamentally-weighted exposure to developed ex-U.S. large-cap value equities. The fund has demonstrated strong recent performance, delivering a 24.57% return both year-to-date and over the past year as of August 25, 2025. Its risk profile is characterized as medium, with a beta of 0.82 indicating lower volatility relative to the broader market, and its portfolio is highly diversified across approximately 1147 holdings, minimizing concentration risk. The strategy, which weights securities by book value, cash flow, sales, and dividends, has resulted in a 3.01% trailing dividend yield. However, a key consideration is its 0.43% annual expense ratio, which is substantially higher than key competitors such as the Vanguard International High Dividend Yield ETF (VYMI) at 0.17% and the Schwab Fundamental International Equity ETF (FNDF) at 0.25%. This cost disadvantage presents a potential headwind to long-term performance, particularly if the fund's stock-selection methodology does not continue to outperform its cheaper rivals.

Key Decisions for Investors

• Investors seeking exposure to fundamentally-weighted ex-U.S. equities should weigh PXF's strong recent performance of 24.57% against its relatively high 0.43% expense ratio.
• A critical comparison should be made with lower-cost and larger alternatives like VYMI and FNDF, as the significant fee differential could erode long-term returns.
• It is prudent to monitor whether PXF's specific RAFI methodology can consistently generate alpha sufficient to justify its premium cost structure beyond the recent period of outperformance.